quizartinib
daiichi sankyo
['intrigue', 'quantum-first']
 intrigued by the data from quantum-first. i am not at #eha2022 but would also love to see subset analyses from study based on age (&lt;60 y/o vs &gt;60 y/o) and ideally 70-75 y/o group since no other study included this subset with induction + flt3i.
Associate Prof of Med @UNC_Lineberger | Oncologist | Clinical Trialist- #AML & #MDS | Alum of Osler Residency & Hopkins Oncology | Diehard NYG fan| Views my own